Abstracts & Posters

View several Optinose studies and presentations to learn more about our products and potential candidates for future products.

• American College of Allergy, Asthma & Immunology — Annual Scientific Meeting

  October 26-30, 2017
• EDS-FLU (Exhalation Delivery System With Fluticasone) Improves Peak Nasal Inspiratory Flow (PNIF) in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
• EDS-FLU (Exhalation Delivery System With Fluticasone) Improves Sleep in Patients With Chronic Rhinosinusitis (CRS) With Nasal Polyps
• Potential for Population-Level Healthcare Quality Improvement With a New Treatment Modality for Chronic Rhinosinusitis (CRS)

• Academy of Managed Care Pharmacy — Nexus Meeting

  October 16-19, 2017
• Economic Impact of Reduction in Surgical Eligibility Among Newly Diagnosed Patients With Chronic Rhinosinusitis (CRS)—A Managed Care Cost-Offset Model

• American Academy of Otolaryngology — Head and Neck Surgery Annual Meeting

  September 10-13, 2017
• Exhalation Delivery System With Fluticasone (EDS-FLU) for Chronic Rhinosinusitis (CRS): Integrated NAVIGATE I and NAVIGATE II Results  

• American Rhinologic Society

  September 8-9, 2017
• Exhalation Delivery System With Fluticasone (EDS-FLU) for Treatment of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Integrated Safety Results From NAVIGATE I and NAVIGATE II
• Systemic Exposure to Fluticasone Propionate (FP) With an Intranasal Exhalation Delivery System With FP (EDS-FLU) 186 μg Versus Observed, Dose-Normalized and Reported Orally Inhaled Flovent® HFA 220 μg

• American Rhinologic Society Spring Meeting at COSM

  April 27-28, 2017
• NAVIGATE I: EDS-FLU (Exhalation Delivery System With Fluticasone) for Symptoms of Chronic Rhinosinusitis With Nasal Polyps

• American Academy of Allergy, Asthma, and Immunology

  March 3-6, 2017
• NAVIGATE I: A Randomized, Double-Blind Trial of an Exhalation Delivery System with Fluticasone (EDS-FLU) for Treatment of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
• EXHANCE-3: A Phase III, 3-Month Study of Safety and Efficacy of an Exhalation Delivery System with Fluticasone (EDS-FLU) in Patients With Chronic Rhinosinusitis With (CRSwNP) and Without Nasal Polyps (CRSsNP)
• Health Care for Chronic Rhinosinusitis (CRS) Symptoms—A Cross-Sectional, Population-Based Survey of US Adults Meeting Symptom Criteria for CRS

• American College of Allergy, Asthma, and Immunology

  November 10-14, 2016
• NAVIGATE II: EDS-FLU (Exhalation Delivery System for Fluticasone) for Symptoms of Chronic Rhinosinusitis with Nasal Polyps

• American Rhinologic Society

  September 16-19, 2016
• EXHANCE-12: A One Year Study of Safety and Efficacy of a Fluticasone Propionate Exhalation Delivery System (FLU-EDS), in Patients with Chronic Rhinosinusitis With and Without Polyps
• NAVIGATE II: A Randomized Double-Blind Trial of Fluticasone Propionate Exhalation Delivery System (FLU-EDS) for Treatment of Chronic Rhinosinusitis (CRS) with Nasal Polyps (Nasal Polyposis)
• A Cross-Sectional Population-Based Survey of the Prevalence, Disease Burden, and Characteristics of the US Adult Population with Symptoms of Chronic Rhinosinusitis (CRS)